World / Health & Beauty
Men And Women With History Of Concussion Mend Differently, Study Finds - Concussion Treatment Needs To Be More Individualized
10.07.2008 05:14
medicalnewstoday.com
Female soccer players and soccer players who have had a previous concussion recuperate differently from males or players without a history of concussion, new research released at the 2008 American Orthopaedic Society for Sports Medicine Annual Meeting at JW Marriott Orland Grande Lakes shows. The study found that prior history of concussion and gender account for significant differences in test results following the injury.
World
Neurology
Public Health Experts Provide Update On Current Infectious Diseases Threats
10.07.2008 05:14
medicalnewstoday.com
Updates on the impact of climate changes on insect-borne diseases, the control of MRSA infections, and the importance of childhood immunizations were presented at a news conference at the National Press Club in Washington, D.C. The news conference, sponsored by the National Foundation for Infectious Diseases (NFID), also addressed the growing challenge of prevention and treatment of infections due to drug resistant bacteria.
World
Infectious Diseases
Cerimon Pharmaceuticals Initiates Phase II Study To Evaluate Simulect(R) (Basiliximab) For Noninfectious Uveitis
10.07.2008 05:14
medicalnewstoday.com
Cerimon Pharmaceuticals, Inc., announced it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, a chronic and potentially sight-threatening inflammation of the eye. The randomized, double-masked, placebo-controlled study will evaluate the safety and efficacy of Simulect as maintenance therapy in 56 patients.
World
Gastroenterology
Cerimon Pharmaceuticals Initiates Phase II Study To Evaluate Simulect(R) (Basiliximab) For Noninfectious Uveitis
10.07.2008 05:13
medicalnewstoday.com
Cerimon Pharmaceuticals, Inc., announced it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, a chronic and potentially sight-threatening inflammation of the eye. The randomized, double-masked, placebo-controlled study will evaluate the safety and efficacy of Simulect as maintenance therapy in 56 patients.
World
Eyesight Disorders
Survey: Most Effective Dental Braces Are Least Attractive
10.07.2008 05:13
medicalnewstoday.com
When it comes to the attractiveness of orthodontic braces, less metal is better, according to a recent survey. The study of the public's attitude about the attractiveness of various styles of braces indicates that the types of dental appliances with no visible metal were considered the most attractive.
World
Dentistry
Kidney Disease Linked To Lower Medication Use After Heart Attack
10.07.2008 05:13
medicalnewstoday.com
Patients with kidney disease especially end-stage renal disease (ESRD) requiring dialysis are less likely to receive recommended medications after a heart attack, reports a study in the September 2008 Clinical Journal of the American Society of Nephrology (CJASN).
World
Cardiology
Novel Approach May Protect Against Heart Attack Injury
10.07.2008 05:13
medicalnewstoday.com
Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.
World
Cardiology
Mayo Clinic Spearheads Research To Discover Unsuspected Gene For Atrial Fibrillation
10.07.2008 05:13
medicalnewstoday.com
Mayo Clinic researchers have found a gene mutation linked to one family's hereditary form of atrial fibrillation. Researchers hope this discovery will lead to better understanding of the disease and, eventually, better ways to predict, prevent and treat the heart rhythm problem. The study was based on a large family with an inherited form of atrial fibrillation in 11 relatives.
World
Cardiology
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results Of APD791 For The Treatment Of Arterial Thrombosis
10.07.2008 05:13
medicalnewstoday.com
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced positive results from a multiple-ascending dose Phase 1b clinical trial of APD791 to evaluate the compound's safety, pharmacokinetics and pharmacodynamics. APD791 is Arena's internally discovered oral drug candidate intended for the treatment of arterial thrombosis and other related conditions.
World
Cardiology
Herceptin Targets Breast Cancer Stem Cells
10.07.2008 05:13
medicalnewstoday.com
A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive Cancer Center. The gene, HER2, causes cancer stem cells to multiply and spread, explaining why HER2 has been linked to a more aggressive type of breast cancer and to metastatic disease, in which the cancer has spread beyond the breast, the researchers say.
World
Cancer
Researchers Uncover Health Benefits Of Aspirin In The Prevention And Treatment Of Osteoporosis
10.07.2008 05:12
medicalnewstoday.com
Researchers at the University of Southern California, School of Dentistry have uncovered the health benefits of aspirin in the fight against osteoporosis. Forty-four million Americans, 68 percent of whom are women, suffer from the debilitating effects of osteoporosis according to the National Institute of Health. One out of every two women and one in four men over 50 will have an osteoporosis-related fracture in their lifetime.
World
Orthopedics
Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study For Gout
10.07.2008 05:12
medicalnewstoday.com
Ardea Biosciences, Inc. (Nasdaq: RDEA) announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patients with hyperuricemia. Gout, also known as metabolic arthritis, is a painful and debilitating disease caused by abnormally elevated levels of uric acid in the blood stream, and is the most common form of inflammatory arthritis in men over 40. The Company also announced that gout specialist, Dr.
World
Arthritis
Prostate Cancer Vaccines More Effective With Hormone Therapy
10.07.2008 04:18
medicalnewstoday.com
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research. Philip M. Arlen, M.D.
World
Urology
Older People Are Having Sex, And Loving It
10.07.2008 04:18
medicalnewstoday.com
According to a study published on bmj.com, the number of 70 year olds that are having sex - and saying it is good sex - is increasing. Further, more older women are indicating specific satisfaction with their sex lives. Much of the research on sexual activity concerns younger people, and our objective knowledge about sexual behaviors among older people is quite limited.
World
Sexology
Pharmacists Urged To Implement New Opioids Guidance Immediately
10.07.2008 04:18
medicalnewstoday.com
Following the National Patient Safety Agency (NPSA) Rapid Response Report into opioids, the Royal Pharmaceutical Society of Great Britain is reminding pharmacists to remain vigilant in ensuring that the correct dosages are given to individual patients.
World
Pharmaceutics
English